Most read article(s)

You have access
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Krishna Sriram and Paul A. Insel

Molecular Pharmacology April 2018, 93 (4) 251-258; DOI: https://doi.org/10.1124/mol.117.111062
You have access
The Histamine H₃ Receptor: Structure, Pharmacology, and Function
Gustavo Nieto-Alamilla, Ricardo Márquez-Gómez, Ana-Maricela García-Gálvez, Guadalupe-Elide Morales-Figueroa and José-Antonio Arias-Montaño

Molecular Pharmacology November 2016, 90 (5) 649-673; DOI: https://doi.org/10.1124/mol.116.104752
You have access
Tumor Microenvironment Targeting and Responsive Peptide-Based Nanoformulations for Improved Tumor Therapy
Hao Qin, Yanping Ding, Ayeesha Mujeeb, Ying Zhao and Guangjun Nie

Molecular Pharmacology September 2017, 92 (3) 219-231; DOI: https://doi.org/10.1124/mol.116.108084
Open Access
Characterization of Vixotrigine, a Broad-Spectrum Voltage-Gated Sodium Channel Blocker
Christopher A Hinckley, Yuri Kuryshev, Alissende Sers, Alexander Barre, Bruno Buisson, Himanshu Naik and Mihaly Hajos

Molecular Pharmacology January 2021, 99 (1) 49-59; DOI: https://doi.org/10.1124/molpharm.120.000079
You have access
Dehydrocrenatidine Is a Novel Janus Kinase Inhibitor
Jing Zhang, Ning Zhu, Yuping Du, Qifeng Bai, Xing Chen, Jing Nan, Xiaodong Qin, Xinxin Zhang, Jianwen Hou, Qin Wang and Jinbo Yang

Molecular Pharmacology April 2015, 87 (4) 572-581; DOI: https://doi.org/10.1124/mol.114.095208
Open Access
Wnt Signaling and Drug Resistance in Cancer
Zheng Zhong and David M. Virshup

Molecular Pharmacology February 2020, 97 (2) 72-89; DOI: https://doi.org/10.1124/mol.119.117978
You have access
Current Knowledge and Perspectives on Histamine H₁ and H₂ Receptor Pharmacology: Functional Selectivity, Receptor Crosstalk, and Repositioning of Classic Histaminergic Ligands
Federico Monczor and Natalia Fernandez

Molecular Pharmacology November 2016, 90 (5) 640-648; DOI: https://doi.org/10.1124/mol.116.105981
You have access
Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc
Seiji Sato, Xi-Ping Huang, Wesley K. Kroeze and Bryan L. Roth

Molecular Pharmacology December 2016, 90 (6) 726-737; DOI: https://doi.org/10.1124/mol.116.106112
You have access
Dysregulation of Angiotensin Converting Enzyme 2 Expression and Function in Comorbid Disease Conditions Possibly Contributes to Coronavirus Infectious Disease 2019 Complication Severity
Safaa H Hammoud, Zena Wehbe, Samar Abdelhady, Firas Kobeissy, Ali H. Eid and Ahmed F. El-Yazbi

Molecular Pharmacology January 2021, 99 (1) 17-28; DOI: https://doi.org/10.1124/molpharm.120.000119
You have access
Biased Agonism in Drug Discovery—Is It Too Soon to Choose a Path?
Martin C. Michel and Steven J. Charlton

Molecular Pharmacology April 2018, 93 (4) 259-265; DOI: https://doi.org/10.1124/mol.117.110890

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals